|
|
OTC Healthcare in Finland to 2013
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 190 seiten | |||||||||
| Inhalt der Studie: |
Introduction
This databook provides key data and information on the OTC healthcare market in Finland. This report is a comprehensive resource for market, category and segment level data including val.....
Introduction This databook provides key data and information on the OTC healthcare market in Finland. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share. Scope *Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits *Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data *Category level company and brand share as well as distribution share information for 2007 and 2008 *Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description Highlights The market for OTC healthcare in Finland increased at a compound annual growth rate of 3.6% between 2003 and 2008. The analgesics category led the OTC healthcare market in Finland, accounting for a share of 21.1%. Leading players in Finnish OTC healthcare market include GlaxoSmithKline Plc, Johnson & Johnson and Orion Corporation. Reasons to Purchase *Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Finland *Design effective marketing and sales strategies by identifying key market categories and segments *Identify key players within the market to plan lucrative M&A, partnerships and agreements Report Highlights [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS Chapter 1 Executive Summary 2 Summary market level: OTC healthcare 2 Summary category level: analgesics 3 Summary category level: topical OTC medicines 4 Summary category level: cough and cold preparations 5 Summary category level: indigestion preparations 6 Summary category level: medicated skin products 7 Summary category level: first aid kits 8 Summary category level: other OTC healthcare products 9 Summary category level: plasters & bandages 10 Summary category level: traditional medicines 11 Summary category level: vitamins and minerals 12 Chapter 2 Introduction 13 What is this report about? 13 How to use this report 13 Market definition 14 Chapter 3 Market Overview 29 Value analysis (Euro), 2003?08 29 Value analysis (Euro), 2008?13 31 Value analysis (US dollars), 2003?08 33 Value analysis (US dollars), 2008?13 34 Company and brand share analysis 36 Distribution analysis 43 Chapter 4 Leading Company Profiles 45 GlaxoSmithKline Plc 45 Johnson & Johnson 48 Chapter 5 Category Analysis: Analgesics 50 Value analysis (Euro), 2003?08 50 Value analysis (Euro), 2008?13 51 Value analysis (US dollars), 2003?08 53 Value analysis (US dollars), 2008?13 54 Company and brand share analysis 56 Distribution analysis 59 Chapter 6 Category Analysis: Topical OTC Medicines 61 Value analysis (Euro), 2003?08 61 Value analysis (Euro), 2008?13 62 Value analysis (US dollars), 2003?08 64 Value analysis (US dollars), 2008?13 65 Company and brand share analysis 67 Distribution analysis 70 Chapter 7 Category Analysis: Cough and Cold Preparations 72 Value analysis (Euro), 2003?08 72 Value analysis (Euro), 2008?13 73 Value analysis (US dollars), 2003?08 75 Value analysis (US dollars), 2008?13 76 Company and brand share analysis 78 Distribution analysis 81 Chapter 8 Category Analysis: Indigestion Preparations 83 Value analysis (Euro), 2003?08 83 Value analysis (Euro), 2008?13 84 Value analysis (US dollars), 2003?08 86 Value analysis (US dollars), 2008?13 86 Company and brand share analysis 88 Distribution analysis 91 Chapter 9 Category Analysis: Medicated Skin Products 93 Value analysis (Euro), 2003?08 93 Value analysis (Euro), 2008?13 94 Value analysis (US dollars), 2003?08 96 Value analysis (US dollars), 2008?13 97 Company and brand share analysis 99 Distribution analysis 102 Chapter 10 Category Analysis: First Aid Kits 104 Value analysis (Euro), 2003?08 104 Value analysis (Euro), 2008?13 105 Value analysis (US dollars), 2003?08 106 Value analysis (US dollars), 2008?13 106 Company and brand share analysis 107 Distribution analysis 110 Chapter 11 Category Analysis: Other OTC Healthcare Products 112 Value analysis (Euro), 2003?08 112 Value analysis (Euro), 2008?13 113 Value analysis (US dollars), 2003?08 115 Value analysis (US dollars), 2008?13 116 Company and brand share analysis 118 Distribution analysis 121 Chapter 12 Category Analysis: Plasters & Bandages 123 Value analysis (Euro), 2003?08 123 Value analysis (Euro), 2008?13 124 Value analysis (US dollars), 2003?08 126 Value analysis (US dollars), 2008?13 127 Company and brand share analysis 129 Distribution analysis 132 Chapter 13 Category Analysis: Traditional Medicines 134 Value analysis (Euro), 2003?08 134 Value analysis (Euro), 2008?13 135 Value analysis (US dollars), 2003?08 136 Value analysis (US dollars), 2008?13 136 Company and brand share analysis 137 Distribution analysis 139 Chapter 14 Category Analysis: Vitamins and Minerals 141 Value analysis (Euro), 2003?08 141 Value analysis (Euro), 2008?13 142 Value analysis (US dollars), 2003?08 144 Value analysis (US dollars), 2008?13 144 Company and brand share analysis 146 Distribution analysis 149 Chapter 15 Country Comparison 151 Value 151 Market share 155 Chapter 16 PESTLE Analysis 156 Summary 156 Political analysis 158 Economic analysis 161 Social analysis 164 Technological analysis 167 Legal analysis 171 Environmental analysis 174 Chapter 17 New Product Development 177 Product launches over time 177 Recent product launches 179 Chapter 18 Macroeconomic Profile 180 Macroeconomic indicators 180 Chapter 19 Research Methodology 185 Methodology overview 185 Secondary research 186 Market modeling 187 Creating an initial data model 187 Revising the initial data model 187 Creating a final estimate 188 Creating demographic value splits 188 Primary research 188 Data finalization 189 Ongoing research 189 Chapter 20 APPENDIX 190 Future readings 190 How to contact experts in your industry 190 Disclaimer 190 LIST OF FIGURES Figure 1: Finland OTC healthcare value and value forecast, 2003?13 (€m, nominal prices) 32 Figure 2: Finland OTC healthcare category growth comparison, by value, 2003?13 35 Figure 3: Finland OTC healthcare company share, by value, 2007?08 (%) 40 Figure 4: Finland OTC healthcare distribution channels, by value, 2007?08 (%) 44 Figure 5: Finland analgesics value and value forecast, 2003?13 (€m, nominal prices) 52 Figure 6: Finland analgesics category growth comparison, by value, 2003?13 55 Figure 7: Finland analgesics company share, by value, 2007?08 (%) 57 Figure 8: Finland analgesics distribution channels, by value, 2007?08 (%) 60 Figure 9: Finland topical OTC medicines value and value forecast, 2003?13 (€m, nominal prices) 63 Figure 10: Finland topical OTC medicines category growth comparison, by value, 2003?13 66 Figure 11: Finland topical OTC medicines company share, by value, 2007?08 (%) 68 Figure 12: Finland topical OTC medicines distribution channels, by value, 2007?08 (%) 71 Figure 13: Finland cough and cold preparations value and value forecast, 2003?13 (€m, nominal prices) 74 Figure 14: Finland cough and cold preparations category growth comparison, by value, 2003?13 77 Figure 15: Finland cough and cold preparations company share, by value, 2007?08 (%) 79 Figure 16: Finland cough and cold preparations distribution channels, by value, 2007?08 (%) 82 Figure 17: Finland indigestion preparations value and value forecast, 2003?13 (€m, nominal prices) 85 Figure 18: Finland indigestion preparations category growth comparison, by value, 2003?13 87 Figure 19: Finland indigestion preparations company share, by value, 2007?08 (%) 89 Figure 20: Finland indigestion preparations distribution channels, by value, 2007?08 (%) 92 Figure 21: Finland medicated skin products value and value forecast, 2003?13 (€m, nominal prices) 95 Figure 22: Finland medicated skin products category growth comparison, by value, 2003?13 98 Figure 23: Finland medicated skin products company share, by value, 2007?08 (%) 100 Figure 24: Finland medicated skin products distribution channels, by value, 2007?08 (%) 103 Figure 25: Finland first aid kits value and value forecast, 2003?13 (€m, nominal prices) 105 Figure 26: Finland first aid kits company share, by value, 2007?08 (%) 108 Figure 27: Finland first aid kits distribution channels, by value, 2007?08 (%) 111 Figure 28: Finland other OTC healthcare products value and value forecast, 2003?13 (€m, nominal prices) 114 Figure 29: Finland other OTC healthcare products category growth comparison, by value, 2003?13 117 Figure 30: Finland other OTC healthcare products company share, by value, 2007?08 (%) 119 Figure 31: Finland other OTC healthcare products distribution channels, by value, 2007?08 (%) 122 Figure 32: Finland plasters & bandages value and value forecast, 2003?13 (€m, nominal prices) 125 Figure 33: Finland plasters & bandages category growth comparison, by value, 2003?13 128 Figure 34: Finland plasters & bandages company share, by value, 2007?08 (%) 130 Figure 35: Finland plasters & bandages distribution channels, by value, 2007?08 (%) 133 Figure 36: Finland traditional medicines value and value forecast, 2003?13 (€m, nominal prices) 135 Figure 37: Finland traditional medicines distribution channels, by value, 2007?08 (%) 140 Figure 38: Finland vitamins and minerals value and value forecast, 2003?13 (€m, nominal prices) 143 Figure 39: Finland vitamins and minerals category growth comparison, by value, 2003?13 145 Figure 40: Finland vitamins and minerals company share, by value, 2007?08 (%) 147 Figure 41: Finland vitamins and minerals distribution channels, by value, 2007?08 (%) 150 Figure 42: Global OTC healthcare market split (value terms, 2008), top five countries 152 Figure 43: Global OTC healthcare market value, 2003–08, top five countries 154 Figure 44: Annual data review process 186 LIST OF TABLES Table 1: OTC healthcare category definitions 15 Table 2: OTC healthcare distribution channels 17 Table 3: Finland OTC healthcare value, 2003?08 (€m, nominal prices) 30 Table 4: Finland OTC healthcare value forecast, 2008?13 (€m, nominal prices) 31 Table 5: Finland OTC healthcare value, 2003?08 ($m, nominal prices) 33 Table 6: Finland OTC healthcare value forecast, 2008?13 ($m, nominal prices) 34 Table 7: Finland OTC healthcare brand share, by value, 2007?08 (%) 36 Table 8: Finland OTC healthcare value, by brand 2007?08 (€m, nominal prices) 38 Table 9: Finland OTC healthcare company share by value, 2007?08 (%) 41 Table 10: Finland OTC healthcare value, by company, 2007?08 (€m, nominal prices) 42 Table 11: Finland OTC healthcare distribution channels, by value, 2007?08 (%) 43 Table 12: Finland OTC healthcare value, by distribution channel, 2007?08 (€m, nominal prices) 43 Table 13: GlaxoSmithKline Plc key facts 45 Table 14: Johnson & Johnson key facts 48 Table 15: Finland analgesics value, 2003?08 (€m, nominal prices) 50 Table 16: Finland analgesics value forecast, 2008?13 (€m, nominal prices) 51 Table 17: Finland analgesics value, 2003?08 ($m, nominal prices) 53 Table 18: Finland analgesics value forecast, 2008?13 ($m, nominal prices) 54 Table 19: Finland analgesics brand share, by value, 2007?08 (%) 56 Table 20: Finland analgesics value, by brand 2007?08 (€m, nominal prices) 56 Table 21: Finland analgesics company share by value, 2007?08 (%) 58 Table 22: Finland analgesics value, by company, 2007?08 (€m, nominal prices) 58 Table 23: Finland analgesics distribution channels, by value, 2007?08 (%) 59 Table 24: Finland analgesics value, by distribution channel, 2007?08 (€m, nominal prices) 59 Table 25: Finland topical OTC medicines value, 2003?08 (€m, nominal prices) 61 Table 26: Finland topical OTC medicines value forecast, 2008?13 (€m, nominal prices) 62 Table 27: Finland topical OTC medicines value, 2003?08 ($m, nominal prices) 64 Table 28: Finland topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 65 Table 29: Finland topical OTC medicines brand share, by value, 2007?08 (%) 67 Table 30: Finland topical OTC medicines value, by brand 2007?08 (€m, nominal prices) 67 Table 31: Finland topical OTC medicines company share by value, 2007?08 (%) 69 Table 32: Finland topical OTC medicines value, by company, 2007?08 (€m, nominal prices) 69 Table 33: Finland topical OTC medicines distribution channels, by value, 2007?08 (%) 70 Table 34: Finland topical OTC medicines value, by distribution channel, 2007?08 (€m, nominal prices) 70 Table 35: Finland cough and cold preparations value, 2003?08 (€m, nominal prices) 72 Table 36: Finland cough and cold preparations value forecast, 2008?13 (€m, nominal prices) 73 Table 37: Finland cough and cold preparations value, 2003?08 ($m, nominal prices) 75 Table 38: Finland cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 76 Table 39: Finland cough and cold preparations brand share, by value, 2007?08 (%) 78 Table 40: Finland cough and cold preparations value, by brand 2007?08 (€m, nominal prices) 78 Table 41: Finland cough and cold preparations company share by value, 2007?08 (%) 80 Table 42: Finland cough and cold preparations value, by company, 2007?08 (€m, nominal prices) 80 Table 43: Finland cough and cold preparations distribution channels, by value, 2007?08 (%) 81 Table 44: Finland cough and cold preparations value, by distribution channel, 2007?08 (€m, nominal prices) 81 Table 45: Finland indigestion preparations value, 2003?08 (€m, nominal prices) 83 Table 46: Finland indigestion preparations value forecast, 2008?13 (€m, nominal prices) 84 Table 47: Finland indigestion preparations value, 2003?08 ($m, nominal prices) 86 Table 48: Finland indigestion preparations value forecast, 2008?13 ($m, nominal prices) 86 Table 49: Finland indigestion preparations brand share, by value, 2007?08 (%) 88 Table 50: Finland indigestion preparations value, by brand 2007?08 (€m, nominal prices) 88 Table 51: Finland indigestion preparations company share by value, 2007?08 (%) 90 Table 52: Finland indigestion preparations value, by company, 2007?08 (€m, nominal prices) 90 Table 53: Finland indigestion preparations distribution channels, by value, 2007?08 (%) 91 Table 54: Finland indigestion preparations value, by distribution channel, 2007?08 (€m, nominal prices) 91 Table 55: Finland medicated skin products value, 2003?08 (€m, nominal prices) 93 Table 56: Finland medicated skin products value forecast, 2008?13 (€m, nominal prices) 94 Table 57: Finland medicated skin products value, 2003?08 ($m, nominal prices) 96 Table 58: Finland medicated skin products value forecast, 2008?13 ($m, nominal prices) 97 Table 59: Finland medicated skin products brand share, by value, 2007?08 (%) 99 Table 60: Finland medicated skin products value, by brand 2007?08 (€m, nominal prices) 99 Table 61: Finland medicated skin products company share by value, 2007?08 (%) 101 Table 62: Finland medicated skin products value, by company, 2007?08 (€m, nominal prices) 101 Table 63: Finland medicated skin products distribution channels, by value, 2007?08 (%) 102 Table 64: Finland medicated skin products value, by distribution channel, 2007?08 (€m, nominal prices) 102 Table 65: Finland first aid kits value, 2003?08 (€m, nominal prices) 104 Table 66: Finland first aid kits value forecast, 2008?13 (€m, nominal prices) 105 Table 67: Finland first aid kits value, 2003?08 ($m, nominal prices) 106 Table 68: Finland first aid kits value forecast, 2008?13 ($m, nominal prices) 106 Table 69: Finland first aid kits brand share, by value, 2007?08 (%) 107 Table 70: Finland first aid kits value, by brand 2007?08 (€m, nominal prices) 107 Table 71: Finland first aid kits company share by value, 2007?08 (%) 109 Table 72: Finland first aid kits value, by company, 2007?08 (€m, nominal prices) 109 Table 73: Finland first aid kits distribution channels, by value, 2007?08 (%) 110 Table 74: Finland first aid kits value, by distribution channel, 2007?08 (€m, nominal prices) 110 Table 75: Finland other OTC healthcare products value, 2003?08 (€m, nominal prices) 112 Table 76: Finland other OTC healthcare products value forecast, 2008?13 (€m, nominal prices) 113 Table 77: Finland other OTC healthcare products value, 2003?08 ($m, nominal prices) 115 Table 78: Finland other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 116 Table 79: Finland other OTC healthcare products brand share, by value, 2007?08 (%) 118 Table 80: Finland other OTC healthcare products value, by brand 2007?08 (€m, nominal prices) 118 Table 81: Finland other OTC healthcare products company share by value, 2007?08 (%) 120 Table 82: Finland other OTC healthcare products value, by company, 2007?08 (€m, nominal prices) 120 Table 83: Finland other OTC healthcare products distribution channels, by value, 2007?08 (%) 121 Table 84: Finland other OTC healthcare products value, by distribution channel, 2007?08 (€m, nominal prices) 121 Table 85: Finland plasters & bandages value, 2003?08 (€m, nominal prices) 123 Table 86: Finland plasters & bandages value forecast, 2008?13 (€m, nominal prices) 124 Table 87: Finland plasters & bandages value, 2003?08 ($m, nominal prices) 126 Table 88: Finland plasters & bandages value forecast, 2008?13 ($m, nominal prices) 127 Table 89: Finland plasters & bandages brand share, by value, 2007?08 (%) 129 Table 90: Finland plasters & bandages value, by brand 2007?08 (€m, nominal prices) 129 Table 91: Finland plasters & bandages company share by value, 2007?08 (%) 131 Table 92: Finland plasters & bandages value, by company, 2007?08 (€m, nominal prices) 131 Table 93: Finland plasters & bandages distribution channels, by value, 2007?08 (%) 132 Table 94: Finland plasters & bandages value, by distribution channel, 2007?08 (€m, nominal prices) 132 Table 95: Finland traditional medicines value, 2003?08 (€m, nominal prices) 134 Table 96: Finland traditional medicines value forecast, 2008?13 (€m, nominal prices) 135 Table 97: Finland traditional medicines value, 2003?08 ($m, nominal prices) 136 Table 98: Finland traditional medicines value forecast, 2008?13 ($m, nominal prices) 136 Table 99: Finland traditional medicines brand share, by value, 2007?08 (%) 137 Table 100: Finland traditional medicines value, by brand 2007?08 (€m, nominal prices) 137 Table 101: Finland traditional medicines company share by value, 2007?08 (%) 138 Table 102: Finland traditional medicines value, by company, 2007?08 (€m, nominal prices) 138 Table 103: Finland traditional medicines distribution channels, by value, 2007?08 (%) 139 Table 104: Finland traditional medicines value, by distribution channel, 2007?08 (€m, nominal prices) 139 Table 105: Finland vitamins and minerals value, 2003?08 (€m, nominal prices) 141 Table 106: Finland vitamins and minerals value forecast, 2008?13 (€m, nominal prices) 142 Table 107: Finland vitamins and minerals value, 2003?08 ($m, nominal prices) 144 Table 108: Finland vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 144 Table 109: Finland vitamins and minerals brand share, by value, 2007?08 (%) 146 Table 110: Finland vitamins and minerals value, by brand 2007?08 (€m, nominal prices) 146 Table 111: Finland vitamins and minerals company share by value, 2007?08 (%) 148 Table 112: Finland vitamins and minerals value, by company, 2007?08 (€m, nominal prices) 148 Table 113: Finland vitamins and minerals distribution channels, by value, 2007?08 (%) 149 Table 114: Finland vitamins and minerals value, by distribution channel, 2007?08 (€m, nominal prices) 149 Table 115: Global OTC healthcare market value, 2008 151 Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 154 Table 117: Leading players, top five countries 155 Table 118: Analysis of Finland’s political landscape 158 Table 119: Analysis of Finland’s economy 161 Table 120: Analysis of Finland’s social system 164 Table 121: Analysis of Finland’s technology landscape 167 Table 122: Hourly labor cost in EU countries 169 Table 123: Patents received from USPTO 170 Table 124: Analysis of Finland’s legal landscape 171 Table 125: Analysis of Finland’s environmental landscape 174 Table 126: Finland OTC healthcare new product launches reports, by company (top five companies), 2008 177 Table 127: Finland OTC healthcare new product launches SKUs, by company (top five companies), 2008 177 Table 128: Finland OTC healthcare new product launches (reports), by flavor and fragrances (top 10 flavors), 2008 178 Table 129: Finland OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2008 178 Table 130: Finland OTC healthcare new product launches (reports), by package tags or claims (top 10 claims), 2008 179 Table 131: Finland OTC healthcare new product launches - recent five launches 2008 179 Table 132: Finland population, by age group, 2003?08 (millions) 180 Table 133: Finland population forecast, by age group, 2008?13 (millions) 181 Table 134: Finland population, by gender, 2003?08 (millions) 181 Table 135: Finland population forecast, by gender, 2008?13 (millions) 182 Table 136: Finland nominal GDP, 2003?08 (€bn, nominal prices) 182 Table 137: Finland nominal GDP forecast, 2008?13 (€bn, nominal prices) 182 Table 138: Finland real GDP, 2003?08 (€bn, 2000 prices) 183 Table 139: Finland real GDP forecast, 2008?13 (€bn, 2000 prices) 183 Table 140: Finland real GDP, 2003?08 ($bn, 2000 prices) 183 Table 141: Finland real GDP forecast, 2008?13 ($bn, 2000 prices) 184 Table 142: Finland consumer price index, 2003?08 (2000=100) 184 Table 143: Finland consumer price index, 2008?13 (2000=100) 184 [Inhaltsverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


